BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32480168)

  • 1. Src family kinases inhibition by dasatinib blocks initial and subsequent platelet deposition on collagen under flow, but lacks efficacy with thrombin generation.
    Zhang Y; Diamond SL
    Thromb Res; 2020 Aug; 192():141-151. PubMed ID: 32480168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-GPVI Fab reveals distinct roles for GPVI signaling in the first platelet layer and subsequent layers during microfluidic clotting on collagen with or without tissue factor.
    Zhang Y; Trigani KT; Shankar KN; Crossen J; Liu Y; Sinno T; Diamond SL
    Thromb Res; 2022 Oct; 218():112-129. PubMed ID: 36037547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dasatinib Inhibits Procoagulant and Clot Retracting Activities of Human Platelets.
    Beke Debreceni I; Mezei G; Batár P; Illés Á; Kappelmayer J
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31683623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombus growth and embolism on tissue factor-bearing collagen surfaces under flow: role of thrombin with and without fibrin.
    Colace TV; Muthard RW; Diamond SL
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1466-76. PubMed ID: 22516070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrin, γ'-fibrinogen, and transclot pressure gradient control hemostatic clot growth during human blood flow over a collagen/tissue factor wound.
    Muthard RW; Welsh JD; Brass LF; Diamond SL
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):645-54. PubMed ID: 25614284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics of Thrombin Generation and Flux from Clots during Whole Human Blood Flow over Collagen/Tissue Factor Surfaces.
    Zhu S; Lu Y; Sinno T; Diamond SL
    J Biol Chem; 2016 Oct; 291(44):23027-23035. PubMed ID: 27605669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimum wound size for clotting: flowing blood coagulates on a single collagen fiber presenting tissue factor and von Willebrand factor.
    Zhu S; Tomaiuolo M; Diamond SL
    Integr Biol (Camb); 2016 Aug; 8(8):813-20. PubMed ID: 27339024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiscale simulation of thrombus growth and vessel occlusion triggered by collagen/tissue factor using a data-driven model of combinatorial platelet signalling.
    Lu Y; Lee MY; Zhu S; Sinno T; Diamond SL
    Math Med Biol; 2017 Dec; 34(4):523-546. PubMed ID: 27672182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systems biology of coagulation initiation: kinetics of thrombin generation in resting and activated human blood.
    Chatterjee MS; Denney WS; Jing H; Diamond SL
    PLoS Comput Biol; 2010 Sep; 6(9):. PubMed ID: 20941387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-targeting sensor reveals thrombin gradients within blood clots forming in microfluidic assays and in mouse.
    Welsh JD; Colace TV; Muthard RW; Stalker TJ; Brass LF; Diamond SL
    J Thromb Haemost; 2012 Nov; 10(11):2344-53. PubMed ID: 22978514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishing the Transient Mass Balance of Thrombosis: From Tissue Factor to Thrombin to Fibrin Under Venous Flow.
    Zhu S; Chen J; Diamond SL
    Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1528-1536. PubMed ID: 29724819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating thrombin-loaded fibrin in whole blood clot microfluidic assay via fluorogenic peptide.
    Crossen J; Shankar KN; Diamond SL
    Biophys J; 2023 Feb; 122(4):697-712. PubMed ID: 36635963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced model to predict thrombin and fibrin during thrombosis on collagen/tissue factor under venous flow: Roles of γ'-fibrin and factor XIa.
    Chen J; Diamond SL
    PLoS Comput Biol; 2019 Aug; 15(8):e1007266. PubMed ID: 31381558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrathrombus Fibrin Attenuates Spatial Sorting of Phosphatidylserine Exposing Platelets during Clotting Under Flow.
    Trigani KT; Diamond SL
    Thromb Haemost; 2021 Jan; 121(1):46-57. PubMed ID: 32961573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FXIa and platelet polyphosphate as therapeutic targets during human blood clotting on collagen/tissue factor surfaces under flow.
    Zhu S; Travers RJ; Morrissey JH; Diamond SL
    Blood; 2015 Sep; 126(12):1494-502. PubMed ID: 26136249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contact activation of blood coagulation on a defined kaolin/collagen surface in a microfluidic assay.
    Zhu S; Diamond SL
    Thromb Res; 2014 Dec; 134(6):1335-43. PubMed ID: 25303860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apixaban, a direct factor Xa inhibitor, inhibits tissue-factor induced human platelet aggregation in vitro: comparison with direct inhibitors of factor VIIa, XIa and thrombin.
    Wong PC; Jiang X
    Thromb Haemost; 2010 Aug; 104(2):302-10. PubMed ID: 20589316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Side view thrombosis microfluidic device with controllable wall shear rate and transthrombus pressure gradient.
    Muthard RW; Diamond SL
    Lab Chip; 2013 May; 13(10):1883-91. PubMed ID: 23549358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The new tyrosine-kinase inhibitor and anticancer drug dasatinib reversibly affects platelet activation in vitro and in vivo.
    Gratacap MP; Martin V; Valéra MC; Allart S; Garcia C; Sié P; Recher C; Payrastre B
    Blood; 2009 Aug; 114(9):1884-92. PubMed ID: 19494352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex vivo recapitulation of trauma-induced coagulopathy and preliminary assessment of trauma patient platelet function under flow using microfluidic technology.
    Li R; Elmongy H; Sims C; Diamond SL
    J Trauma Acute Care Surg; 2016 Mar; 80(3):440-9. PubMed ID: 27082706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.